Breaking News
The Untold Truth About The Battle Of Lexington
Federal Reserve Balance Sheet
Holter: Gold & Silver "Will Survive The Whole System Burning Down"
Top Tech News
Would you take a DRONE taxi?
Floating cities once seemed like sci-fi. Now the UN is getting on board
IKEA Has Developed a Curtain That Reduces Indoor Air Pollution
Ocean Energy - Wave Power Station
Tesla PickUp Truck 2019 - 10 Mind-Blowing Facts You May Not Know - Tesla News Update
Elon Musk's Surprising Opinion On Electric Planes
SpaceX vs. NASA: Who Will Get to Mars First? | Elon Musk | America Uncovered
'Impossible' meatless patty gets Burger King Whopper test
Tesla Electric Pickup Truck Ram Look-Alike Render Surfaces On Video
Bioscarf: The Prepper's "Gray Man" N-95 Mask You Can Take Anywhere
Anti-Aging Researcher David Sinclair Takes Metformin, NMN, NAD for Longevity
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.